Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | MMP14 | P50281 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8993963 | 0.85 | MMP14 (0.38) | CYP3A4CYP2C9CYP2C19L3MBTL1MMP14 | |
| SCHEMBL6437793 | 0.82 | MEN1 (0.42) | SMN1; SMN2MEN1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL30826512 | 0.82 | LTA4H (0.52) | SMN1; SMN2MEN1KMT2APPARGBCHE | |
| SCHEMBL2677344 | 0.80 | MMP14 (0.55) | SMN1; SMN2MEN1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL9100684 | 0.80 | CKS1B (0.52) | MEN1CYP3A4CYP2C19KMT2ABCHE | |
| SCHEMBL8993937 | 0.79 | SMN1; SMN2 (0.63) | SMN1; SMN2CYP3A4CYP2C9CYP2C19TP53 | |
| SCHEMBL31310823 | 0.79 | AKT1 (0.49) | MEN1KMT2AL3MBTL1BCHEALOX5 | |
| SCHEMBL7299721 | 0.79 | AKT1 (0.52) | MEN1KMT2AL3MBTL1BCHEALOX5 | |
| SCHEMBL11373469 | 0.78 | PPARG (0.47) | SMN1; SMN2MEN1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL4764555 | 0.78 | GBA1 (0.51) | SMN1; SMN2MEN1CYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4204398-A2 | CONJUGATES INCLUDING A DETECTABLE MOIETY | Ventana Medical Systems, Inc. (US) | 2023-07-05 | — | — | EP | disclosed |
| US-20230192658-A1 | CONJUGATES INCLUDING A DETECTABLE MOIETY | VENTANA MEDICAL SYSTEMS, INC. | 2023-06-22 | — | — | US | disclosed |
| US-20230192658-A1 | CONJUGATES INCLUDING A DETECTABLE MOIETY | VENTANA MEDICAL SYSTEMS, INC. | 2023-06-22 | — | — | US | disclosed |
| US-20230192658-A1 | CONJUGATES INCLUDING A DETECTABLE MOIETY | VENTANA MEDICAL SYSTEMS, INC. | 2023-06-22 | — | — | US | disclosed |
| WO-2022043491-A2 | CONJUGATES INCLUDING A DETECTABLE MOIETY | VENTANA MEDICAL SYSTEMS, INC. (US) | 2022-03-03 | — | — | WO | disclosed |
| US-5532171-A | PHENOTHIAZINE DYES FOR PHOTODYNAMIC THERAPY OF CANCER OR IMMUNOASSAY | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-07-02 | — | — | US | disclosed |
| US-5344928-A | Phenothiazine compounds for cancer treatment or immunoassay using chemiluminescence | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-09-06 | — | — | US | disclosed |
| EP-0510668-A2 | Phenothiazine derivatives, their production and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1992-10-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192658-A1 | CONJUGATES INCLUDING A DETECTABLE MOIETY | CD2BP2, CD47, CD44 | SMN1; SMN2 1636/4885MEN1 647/4885CYP3A4 2622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.